THE USE OF TRIENTINE IN PREVENTING THE EFFECTS OF INTERRUPTING PENICILLAMINE THERAPY IN WILSONS-DISEASE

被引：147

作者：

SCHEINBERG, IH

JAFFE, ME

STERNLIEB, I

机构：

[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,DIV GASTROENTEROL LIVER DIS,BRONX,NY 10461

[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,LIVER RES CTR,BRONX,NY 10461

[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,GEN CLIN RES CTR,BRONX,NY 10461

[4] BRONX MUNICIPAL HOSP CTR,BRONX,NY 10461

[5] MERCK SHARP & DOHME RES LABS,W POINT,PA 19486

来源：

关键词：

D O I：

10.1056/NEJM198707233170405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：209 / 213

页数：5

共 19 条

[11]

SCHEINBERG IH, 1986, ORPHAN DISEASES ORPH, P202

[12] WILSONS-DISEASE - INDICATIONS FOR LIVER-TRANSPLANTS [J].

STERNLIEB, I .

[13] PREVENTION OF WILSONS DISEASE IN ASYMPTOMATIC PATIENTS [J].

STERNLIEB, I ;

SCHEINBERG, IH .

[14]

WALSHE JM, 1986, LANCET, V1, P845

[15] PENICILLAMINE, A NEW ORAL THERAPY FOR WILSONS DISEASE [J].

WALSHE, JM .

[16]

WALSHE JM, 1982, LANCET, V1, P643

[17]

WALSHE JM, 1969, LANCET, V2, P1401

[18]

Walshe JM, 1986, ORPHAN DIS ORPHAN DR, P76

[19]

[No title captured]